238 related articles for article (PubMed ID: 33948379)
1. Clinicopathological and molecular features between synchronous and metachronous metastases in colorectal cancer.
Lan YT; Chang SC; Lin PC; Lin CC; Lin HH; Huang SC; Lin CH; Liang WY; Chen WS; Jiang JK; Yang SH; Lin JK
Am J Cancer Res; 2021; 11(4):1646-1658. PubMed ID: 33948379
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases.
Mekenkamp LJ; Koopman M; Teerenstra S; van Krieken JH; Mol L; Nagtegaal ID; Punt CJ
Br J Cancer; 2010 Jul; 103(2):159-64. PubMed ID: 20551951
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and Molecular Features of Colorectal Cancer Patients With Mucinous and Non-Mucinous Adenocarcinoma.
Lan YT; Chang SC; Lin PC; Lin CC; Lin HH; Huang SC; Lin CH; Liang WY; Chen WS; Jiang JK; Lin JK; Yang SH
Front Oncol; 2021; 11():620146. PubMed ID: 33738258
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and Molecular Features of Patients with Early and Late Recurrence after Curative Surgery for Colorectal Cancer.
Lan YT; Chang SC; Lin PC; Lin CC; Lin HH; Huang SC; Lin CH; Liang WY; Chen WS; Jiang JK; Yang SH; Lin JK
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33919924
[TBL] [Abstract][Full Text] [Related]
5. Aberrant Partial Chromosomal Instability With Chemotherapeutically Resistant Metachronous Colorectal Cancer Following a Synchronous Primary Colorectal Cancer: A Case Report.
Dominic JL; Feroz SH; Muralidharan A; Ahmed A; Thirunavukarasu P
Cureus; 2020 Nov; 12(11):e11308. PubMed ID: 33282585
[TBL] [Abstract][Full Text] [Related]
6. Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing.
Kovaleva V; Geissler AL; Lutz L; Fritsch R; Makowiec F; Wiesemann S; Hopt UT; Passlick B; Werner M; Lassmann S
Mol Cancer; 2016 Oct; 15(1):63. PubMed ID: 27756406
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and mutational differences between tumors with multiple metastases and single lung metastasis in colorectal cancer.
Yanai Y; Hayashi T; Akazawa Y; Yatagai N; Tsuyama S; Yao T; Saito T
Oncol Lett; 2020 Jul; 20(1):541-550. PubMed ID: 32565980
[TBL] [Abstract][Full Text] [Related]
8. Higher incidence of metachronous advanced neoplasia in patients with synchronous advanced neoplasia and left-sided colorectal resection for colorectal cancer.
Yabuuchi Y; Imai K; Hotta K; Ito S; Kishida Y; Yamaguchi T; Shiomi A; Kinugasa Y; Yoshida M; Tanaka M; Kawata N; Kakushima N; Takizawa K; Ishiwatari H; Matsubayashi H; Ono H
Gastrointest Endosc; 2018 Aug; 88(2):348-359.e1. PubMed ID: 29574125
[TBL] [Abstract][Full Text] [Related]
9. Synchronous and metachronous liver metastases in patients with colorectal cancer-towards a clinically relevant definition.
Engstrand J; Strömberg C; Nilsson H; Freedman J; Jonas E
World J Surg Oncol; 2019 Dec; 17(1):228. PubMed ID: 31878952
[TBL] [Abstract][Full Text] [Related]
10. Left-sided location is a risk factor for lymph node metastasis of T1 colorectal cancer: a single-center retrospective study.
Mochizuki K; Kudo SE; Ichimasa K; Kouyama Y; Matsudaira S; Takashina Y; Maeda Y; Ishigaki T; Nakamura H; Toyoshima N; Mori Y; Misawa M; Ogata N; Kudo T; Hayashi T; Wakamura K; Sawada N; Ishida F; Miyachi H
Int J Colorectal Dis; 2020 Oct; 35(10):1911-1919. PubMed ID: 32548720
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of disease-free interval in colorectal cancer: Is it time?
Birgin E; Doyon F; Burkert J; Téoule P; Rasbach E; Rahbari M; Reissfelder C; Betzler A; Rahbari NN
Eur J Surg Oncol; 2022 Sep; 48(9):2032-2038. PubMed ID: 35738980
[TBL] [Abstract][Full Text] [Related]
12. Differences in clinical characteristics and mutational pattern between synchronous and metachronous colorectal liver metastases.
Zheng P; Ren L; Feng Q; Zhu D; Chang W; He G; Ji M; Jian M; Lin Q; Yi T; Wei Y; Xu J
Cancer Manag Res; 2018; 10():2871-2881. PubMed ID: 30214282
[TBL] [Abstract][Full Text] [Related]
13. Effect of Tumor Location on Clinicopathological and Molecular Markers in Colorectal Cancer in Eastern China Patients: An Analysis of 2,356 Cases.
Song Y; Wang L; Ran W; Li G; Xiao Y; Wang X; Zhang L; Xing X
Front Genet; 2020; 11():96. PubMed ID: 32161617
[TBL] [Abstract][Full Text] [Related]
14. Synchronous and Metachronous Colorectal Cancers: Distinct Disease Entities or Different Disease Courses?
Huang CS; Yang SH; Lin CC; Lan YT; Chang SC; Wang HS; Chen WS; Lin TC; Lin JK; Jiang JK
Hepatogastroenterology; 2015 Jun; 62(140):838-42. PubMed ID: 26902012
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Implications of Mucinous Differentiation in Metastatic Colorectal Carcinoma Can Be Explained by Distinct Molecular and Clinicopathologic Characteristics.
Khan M; Loree JM; Advani SM; Ning J; Li W; Pereira AAL; Lam M; Raghav K; Morris VK; Broaddus R; Maru D; Overman MJ; Kopetz S
Clin Colorectal Cancer; 2018 Dec; 17(4):e699-e709. PubMed ID: 30205948
[TBL] [Abstract][Full Text] [Related]
16. Relationship between mismatch repair protein,
Fan JZ; Wang GF; Cheng XB; Dong ZH; Chen X; Deng YJ; Song X
World J Clin Cases; 2021 Apr; 9(11):2458-2468. PubMed ID: 33889611
[TBL] [Abstract][Full Text] [Related]
17. Synchronous and metachronous colorectal cancers: distinct disease entities or different disease courses?
Huang CS; Yang SH; Lin CC; Lan YT; Chang SC; Wang HS; Chen WS; Lin TC; Lin JK; Jiang JK
Hepatogastroenterology; 2015; 62(138):286-90. PubMed ID: 25916050
[TBL] [Abstract][Full Text] [Related]
18. Tumor size is an independent risk predictor for metachronous colorectal cancer.
Kato T; Alonso S; Muto Y; Perucho M; Rikiyama T
Oncotarget; 2016 Apr; 7(14):17896-904. PubMed ID: 26910116
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological characteristics and prognosis of synchronous brain metastases from non-small cell lung cancer compared with metachronous brain metastases.
Li J; Zhang X; Wang Y; Jin Y; Song Y; Wang T
Front Oncol; 2024; 14():1400792. PubMed ID: 38841157
[TBL] [Abstract][Full Text] [Related]
20. Lung-molGPA Index Predicts Survival Outcomes of Non-Small-Cell Lung Cancer Patients with Synchronous or Metachronous Brain Metastases.
Chen K; Zhang F; Fan Y; Cheng G
Onco Targets Ther; 2020; 13():8837-8844. PubMed ID: 32943887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
